We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

472 hedge funds and large institutions have $10.3B invested in United Therapeutics in 2022 Q2 according to their latest regulatory filings, with 94 funds opening new positions, 148 increasing their positions, 159 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

165% more call options, than puts

Call options by funds: $79.5M | Put options by funds: $30M

129% more first-time investments, than exits

New positions opened: 94 | Existing positions closed: 41

71% more funds holding in top 10

Funds holding in top 10: 14 → 24 (+10)

32% more capital invested

Capital invested by funds: $7.82B → $10.3B (+$2.5B)

11% more funds holding

Funds holding: 427 → 472 (+45)

0.54% less ownership

Funds ownership: 97.75% → 97.2% (-0.54%)

7% less repeat investments, than reductions

Existing positions increased: 148 | Existing positions reduced: 159

Holders
472
Holders Change
+45
Holders Change %
+10.54%
% of All Funds
7.95%
Holding in Top 10
24
Holding in Top 10 Change
+10
Holding in Top 10 Change %
+71.43%
% of All Funds
0.4%
New
94
Increased
148
Reduced
159
Closed
41
Calls
$79.5M
Puts
$30M
Net Calls
+$49.5M
Net Calls Change
+$32.9M

Top Buyers

1
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$87.8M
2
Deutsche Bank
Deutsche Bank
Germany
+$36.4M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$34.4M
4
Principal Financial Group
Principal Financial Group
Iowa
+$28.1M
5
First Trust Advisors
First Trust Advisors
Illinois
+$26.8M

Top Sellers

1
Wellington Management Group
Wellington Management Group
Massachusetts
-$45M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$36M
3
Citadel Advisors
Citadel Advisors
Florida
-$35.4M
4
ITP
Iron Triangle Partners
Connecticut
-$34.1M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$32.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
151
Algert Global
California
$4.53M -$635K -3,124 -14%
Barclays
152
Barclays
United Kingdom
$4.5M -$168K -824 -4%
EF
153
Empowered Funds
Pennsylvania
$4.34M +$3.75M +18,439 New
WG
154
Winton Group
United Kingdom
$4.26M +$421K +2,071 +13%
COPPSERS
155
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$4.23M +$290K +1,428 +9%
EVM
156
Eaton Vance Management
Massachusetts
$4.17M -$278K -1,365 -7%
SBH
157
Segall Bryant & Hamill
Illinois
$4.12M -$812K -3,992 -19%
IMRF
158
Illinois Municipal Retirement Fund
Illinois
$4.11M +$1.4M +6,872 +65%
Rafferty Asset Management
159
Rafferty Asset Management
New York
$4.09M -$2.76M -13,563 -44%
OA
160
Oak Associates
Ohio
$4.07M – – –
Aviva
161
Aviva
United Kingdom
$4.01M +$3.46M +17,025 New
Twin Tree Management
162
Twin Tree Management
Texas
$3.98M -$7.12M -35,026 -67%
FEG
163
Financial Enhancement Group
Indiana
$3.89M +$3.36M +16,526 New
SCM
164
Silverarc Capital Management
Massachusetts
$3.82M +$283K +1,391 +9%
BNP Paribas Financial Markets
165
BNP Paribas Financial Markets
France
$3.81M -$4.27K -21 -0.1%
Massachusetts Financial Services
166
Massachusetts Financial Services
Massachusetts
$3.8M +$64.2K +316 +2%
Victory Capital Management
167
Victory Capital Management
Texas
$3.75M +$11.8K +58 +0.4%
Walleye Capital
168
Walleye Capital
New York
$3.55M -$1.48M -7,281 -33%
BC
169
Birchview Capital
Vermont
$3.54M -$610K -3,000 -17%
EAM
170
Erste Asset Management
Austria
$3.46M +$114K +563 +4%
KWILP
171
Kiwi Wealth Investments Limited Partnership
New Zealand
$3.45M +$2.97M +14,626 New
N
172
Natixis
France
$3.25M -$22.5M -110,500 -89%
OPERF
173
Oregon Public Employees Retirement Fund
Oregon
$3.11M -$264K -1,300 -9%
ACP
174
Acuta Capital Partners
California
$3.06M +$2.64M +13,000 New
Capital Fund Management (CFM)
175
Capital Fund Management (CFM)
France
$3.03M -$741K -3,643 -22%
5 6
7
8 9

UTHR Hedge Fund Activity: Q2 2022 in Review

472 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2022, worth a combined $10.3B — up 32% from $7.82B a quarter earlier.

Buyers outnumbered sellers: 94 funds opened new UTHR positions and 41 closed out — a net gain of 53 holders — while 148 added to existing stakes and 159 trimmed.

The largest buyer was Assenagon Asset Management, adding an estimated $87.8M. The largest seller was Wellington Management Group, cutting an estimated $45M.

  • 472 institutional investors held United Therapeutics (UTHR) as of Q2 2022, up from 427 in Q1 2022.
  • Funds reported $10.3B of United Therapeutics stock for Q2 2022, up 32% quarter-over-quarter.
  • 94 funds opened new United Therapeutics positions in Q2 2022 and 41 closed out, a net change of +53 holders.
  • The largest United Therapeutics buyer in Q2 2022 was Assenagon Asset Management, an estimated $87.8M added.
  • The largest United Therapeutics seller in Q2 2022 was Wellington Management Group, an estimated $45M sold.

Based on aggregated 13F filings for Q2 2022.